Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Lack of KSR1 stops certain skin tumors in mice.

Activating Kras in mouse skin causes excess skin and hair loss.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The PP2A-B55α protein is essential for brain and skin development in embryos.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Plant extracts can help prevent hair loss and promote hair growth.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Using neurohormones to control keratin can lead to new skin disease treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Researchers created a model to understand heart aging, highlighting the role of microRNAs and identifying key genes and pathways involved.

Gray hair can potentially be reversed, leading to new treatments.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Ursolic acid may help develop new anti-inflammatory drugs by affecting immune cells.